Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.016 | 0.2422 | 0.1148 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0473 | 1 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0336 | 0.6685 | 0.7334 |
Schistosoma mansoni | dihydrofolate reductase | 0.0137 | 0.1869 | 0.2796 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.8435 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0137 | 0.1869 | 0.2796 |
Echinococcus multilocularis | thymidylate synthase | 0.0336 | 0.6685 | 0.7334 |
Brugia malayi | thymidylate synthase | 0.0336 | 0.6685 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0473 | 1 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.8435 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0336 | 0.6685 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0473 | 1 | 0.5 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0137 | 0.1869 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0336 | 0.6685 | 1 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0336 | 0.6685 | 1 |
Onchocerca volvulus | 0.0336 | 0.6685 | 1 | |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0336 | 0.6685 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0473 | 1 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.016 | 0.2422 | 0.1148 |
Trichomonas vaginalis | conserved hypothetical protein | 0.016 | 0.2422 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0473 | 1 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0336 | 0.6685 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.01 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.1259 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.